Loading...

Insulet Corporation

PODDNASDAQ
Healthcare
Medical - Devices
$311.40
$5.17(1.69%)

Insulet Corporation PODD Peers

See (PODD) competitors and their performances in Stock Market.

Peer Comparison Table: Medical - Devices Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
PODD$311.41+1.69%21.8B55.83$5.55N/A
ABT$134.05-2.44%232.6B17.38$7.69+1.71%
BSX-PA$122.18+2.37%175.4B230.53$0.53N/A
BSX$106.66+2.27%154.7B76.34$1.37N/A
SYK$394.50+0.58%149.2B52.83$7.39+0.84%
MDT$86.15+0.21%110.5B23.89$3.61+3.26%
EW$77.87+1.16%45.3B31.88$2.42N/A
DXCM$86.58+2.24%33.4B63.95$1.33N/A
STE$238.36-0.84%23.5B38.65$6.17+0.96%
PHG$24.06+0.56%22.3B80.27$0.30+3.68%
Showing 1 to 10 of 100 results
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

PODD vs ABT Comparison

PODD plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PODD stands at 21.8B. In comparison, ABT has a market cap of 232.6B. Regarding current trading prices, PODD is priced at $311.41, while ABT trades at $134.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PODD currently has a P/E ratio of 55.83, whereas ABT's P/E ratio is 17.38. In terms of profitability, PODD's ROE is +0.35%, compared to ABT's ROE of +0.31%. Regarding short-term risk, PODD is more volatile compared to ABT. This indicates potentially higher risk in terms of short-term price fluctuations for PODD.

Stock Price Comparison

Loading...

Frequently Asked Questions

;